Your search has returned a large number of results. Try searching for a more specific term or phrase.

Transparency Japanese

Our Company 透明性 アルナイラムでは、医療従事者（HCP）および医療機関（HCO）との交流が、患者さんの治療の質や医学研究の価値にポジティブな影響を与えると強く信じています。また、製薬産業における透明性を向上すること、製薬会社とHCPおよびHCOとの関係に対する社会的信頼を強化することにも全力で取り組んでいます。 医療従事者、関係する意思決定者および医療機関が、彼らが提供する専門知識および業務に対して公正な報酬を受けるべきであると私たちは信じています。…

Transparency German

Our Company Transparenz Bei Alnylam sind wir davon überzeugt, dass sich eine Zusammenarbeit zwischen Angehörigen der Gesundheitsberufe (HCPs) und Gesundheitseinrichtungen (HCOs) positiv auf die Behandlungsqualität von Patienten und den Wert…

Transparency Dutch

Our Company Transparantie Bij Alnylam zijn we ervan overtuigd dat interacties met zorgverleners en zorginstellingen een positieve invloed hebben op de kwaliteit van behandelingen van patiënten en de waarde van medisch onderzoek. We zetten…

Amyloidosis

Patients AMYLOIDOSIS Understanding ATTR Amyloidosis Transthyretin-mediated (ATTR) amyloidosis is a rapidly progressive, debilitating disease caused by misfolded transthyretin (TTR) protein, which accumulates as amyloid deposits in various…, hATTR Amyloidosis Perspectives Early diagnosis is very important. – Hannah, living with hATTR amyloidosis  

Primary Hyperoxaluria

Patients PRIMARY HYPEROXALURIA Understanding Primary Hyperoxaluria Type 1 Primary hyperoxaluria (PH) refers to a group of rare inherited disorders of the liver characterized by the overproduction of oxalate, an end-product of metabolism.…, PH1 Perspectives It was a huge shock to our family and her road ahead indeed proved very challenging. – The Skinner Family, living with PH1  

Acute Hepatic Porphyria

Patients ACUTE HEPATIC PORPHYRIA Understanding Acute Hepatic Porphyria Acute hepatic porphyria (AHP) refers to a family of rare genetic diseases characterized by potentially life-threatening attacks and, for some people, chronic…, AHP Perspectives The pain caused by hereditary coproporphyria (HCP) is just something I wouldn’t want anyone to have to go through. – Nathan, diagnosed with Hereditary Coproporphyria (HCP)…

Transparency Danish

Our Company Gennemsigtighed Hos Alnylam mener vi, at interaktioner med sundhedspersonale og sundhedsorganisationer har en positiv indvirkning på kvaliteten af patientbehandlingen og værdien af medicinsk forskning. Det er også vigtigt for os…

Transparency Swedish

Our Company Transparens På Alnylam är vi övertygade om att samverkan med personal och organisationer inom hälso- och sjukvården har en positiv inverkan på kvaliteten på den vård patienterna får och på värdet av medicinsk forskning. Vi…

Transparency Portuguese Brazil

Our Company TRANSPARENCY Na Alnylam, acreditamos que as interações com os profissionais de saúde (HCPs) e as organizações de saúde (HCOs) influenciam positivamente a qualidade do tratamento do paciente e o valor da pesquisa médica. Também…

Transparency Luxmbourg

Our Company TRANSPARENCY At Alnylam, we strongly believe that interactions with Health Care Providers (HCPs) and Healthcare Organizations (HCOs) positively influence the quality of patient treatment and the value of medical research. We are…